
This week on The Genetics Podcast, Patrick is joined by Dr. Carl Anderson, Senior Group Leader and Head of the Human Genetics Programme at the Wellcome Sanger Institute, where he leads the Genomics of Inflammation and Immunity Group. They discuss IBDVerse, the single-cell atlas Carl's team built to map genetic effects on gene regulation across gut cell types, how coding and non-coding variants converge on shared biological pathways in inflammatory bowel disease, and Carl's vision for longitudinal multi-omics cohorts built around the sickest and most underrepresented hospital patients.Show Notes0:00 Intro to The Genetics Podcast00:58 Welcome to Carl02:05 The origins of IBDVerse and mapping genetic effects on gene regulation across gut cell types in IBD05:43 How anti-TNFs and newer genetically-supported IBD drugs have reshaped treatment 08:04 Genetic versus environmental contributions to IBD09:53 Using single-cell data to uncover IBD disease subtypes13:22 Drug sequencing and immunogenicity in treatment response16:52 The backstory of building the IBDVerse atlas at scale20:29 How coding and non-coding IBD variants converge on the same genes and pathways23:38 The case for pathway-specific polygenic risk scores28:17 Building a longitudinal multi-omics dataset to predict IBD progression and drug response30:08 Why Sanger's next cohort targets sick and underrepresented patients rather than healthy volunteers34:07 What Carl looks for when interviewing PhD students and faculty candidates 39:20 A call to junior scientists and closing remarksFind out more:IBDverse study
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.

EP 250: Redefining rare disease realities with Sharon Terry of the Genetic Alliance [Re-run]

EP 248: The blood mutations rewriting cardiovascular risk: Clonal hematopoiesis and polygenic risk with Pradeep Natarajan of Massachusetts General Hospital

EP 247: Why neurons accumulate mutations like clockwork: Somatic mosaicism and neurodegeneration with Christopher Walsh of Boston Children's Hospital

EP 246: Turning a fatal diagnosis into a cure strategy: Accelerating C9orf72 ALS research with Yentli Soto Albrecht of CureC9
Free AI-powered recaps of The Genetics Podcast and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.